Abstract:ContextPrevious studies have shown oseltamivir, a neuraminidase inhibitor, to be effective in preventing influenza and treating experimental influenza.ObjectiveTo evaluate the efficacy and safety of oseltamivir in the treatment of naturally acquired influenza infection.DesignRandomized, placebo-controlled, double-blind study conducted January through March 1998.SettingSixty primary care and university health centers throughout the United States.ParticipantsA total of 629 healthy nonimmunized adults aged 18 to 65 years with febrile respiratory illness of no more than 36 hours' duration with temperature of 38°C or more plus at least 1 respiratory symptom and 1 constitutional symptom.InterventionsIndividuals were randomized to 1 of 3 treatment groups with identical appearing pills: oral oseltamivir phosphate, 75 mg twice daily (n = 211) or 150 mg (n = 209) twice daily, or placebo (n = 209).Main Outcome MeasuresDuration and severity of illness in individuals infected with influenza.ResultsTwo individuals withdrew before receiving medication and were excluded from further analyses. A total of 374 individuals (59.6%) were infected with influenza. Their duration of illness was reduced by more than 30% with both oseltamivir, 75 mg twice daily (median, 71.5 hours; P<.001), and oseltamivir, 150 mg twice daily (median, 69.9 hours; P = .006), compared with placebo (median, 103.3 hours). Severity of illness was reduced by 38% (median score, 597 score-hours; P<.001) with oseltamivir, 75 mg twice daily, and by 35% (median score, 626 score-hours; P<.001) with oseltamivir, 150 mg twice daily, vs placebo (median score, 963 score-hours). Oseltamivir treatment reduced the duration of fever and oseltamivir recipients returned to usual activities 2 to 3 days earlier than placebo recipients (P≤.05). Secondary complications such as bronchitis and sinusitis occurred in 15% of placebo recipients compared with 7% of combined oseltamivir recipients (P = .03). Among all 629 subjects, oseltamivir reduced illness duration (76.3 hours and 74.3 hours for 75 mg and 150 mg, respectively, vs 97.0 hours for placebo; P = .004 for both comparisons) and illness severity (686 score-hours and 629 score-hours for 75 mg and 150 mg, respectively, vs 887 score-hours for placebo; P<.001 for both comparisons). Nausea and vomiting occurred more frequently in both oseltamivir groups (combined, 18.0% and 14.1%, respectively; P = .002) than in the placebo group (7.4% and 3.4%; P<.001).ConclusionsOur data suggest that oral oseltamivir treatment reduces the duration and severity of acute influenza in healthy adults and may decrease the incidence of secondary complications.

Automatic Detection of Pneumonia in Chest X-Ray Images Using Cooperative Convolutional Neural Networks

Pre-linguistic children with cleft palate: Growth of gesture, vocalization, and word use

A Robust CNN Framework with Dual Feedback Feature Accumulation for Detecting Pneumonia Opacity from Chest X-ray Images

Detection of pneumonia in chest X‐ray image based on separable convolutional neural network

Transfer Learning with Deep Convolutional Neural Network (CNN) for Pneumonia Detection Using Chest X-ray

Automated pneumonia detection on chest X-ray images: A deep learning approach with different optimizers and transfer learning architectures

Pneumonia detection in chest X-ray images using an ensemble of deep learning models

Pneumonia Detection On Chest X-Ray Using Radiomic Features And Contrastive Learning

Automated diagnosis of pneumothorax using an ensemble of convolutional neural networks with multi-sized chest radiography images

A new hybrid approach for pneumonia detection using chest X-rays based on ACNN-LSTM and attention mechanism

Enhancing Pneumonia Diagnosis Through Chest Imaging and Machine Learning A Comprehensive Ensemble Approach with Diverse CNN Architectures

Pneumonia Detection on chest X-ray images Using Ensemble of Deep Convolutional Neural Networks

Convolutional Neural Network Based Chest X-Ray Image Classification for Pneumonia Diagnosis

Pneumonia Detection Using an Improved Algorithm Based on Faster R-CNN

A Deep Convolutional Neural Network for Pneumonia Detection in X-ray Images with Attention Ensemble

An Ensemble of Global and Local-Attention Based Convolutional Neural Networks for COVID-19 Diagnosis on Chest X-ray Images

Pneumonia Detection in Chest Radiographs

Automatic ARDS surveillance with chest X-ray recognition using convolutional neural networks

Pneumonia Detection using Chest X-Ray Images and Machine Learning Techniques

Advancing Diagnostic Precision: Leveraging Machine Learning Techniques for Accurate Detection of Covid-19, Pneumonia, and Tuberculosis in Chest X-Ray Images

Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza